EUVIMEDEUVIMED entdecken
Open Access

Clinical, Gender, Socioeconomic Characteristics and Outcomes of Individuals Receiving Hepatitis B Treatment in Ethiopia: 18-Month Follow-Up

Manaswita Tappata, Marina Farah, Chimaobi Anugwom, Eden Bisrat, Amir S Seid, Jose D Debes

The American Journal of Tropical Medicine and Hygiene · 2023

DOI: 10.4269/ajtmh.23-0236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2023. Verfasst von Manaswita Tappata und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota, Minneapolis, Minnesota. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a lack of real-world data on hepatitis B (HBV) treatment in Africa. We conducted a single-center 18-month prospective cohort study in Ethiopia to understand clinical, laboratory, and demographic variables associated with HBV treatment. One hundred fifty HBV-positive patients were included: 51 on treatment, 99 with no treatment. Median age was similar between groups. Those on treatment were more likely to be male (86%), report higher coffee intake (90% versus 70%, P < 0.05), lower khat intake (0% versus 9%, P = 0.08), lower alcohol consumption (0% versus 5%, P = 0.1), and had attained higher levels of education (56% versus 42%, P = 0.19). Individuals on treatment had higher median aspartate aminotransferase (AST), alanine aminotransferase (ALT), HBV DNA, and median Aminotransferase-to-Platelet Ratio Index and Fibrosis-4 scores. At 6 and 12 months, those on treatment showed a decrease in median AST, ALT, and fibrosis scores and had less hepatocellular carcinoma development at 6 months (2% versus 4%). Our study highlights potential demographic disparities in HBV treatment as well as benefits in a real-life setting in Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis BLiver NeoplasmsHumansMaleFemaleFollow-Up StudiesEthiopiaProspective StudiesHepatitis B virusAlanine TransaminaseSocioeconomic FactorsFibrosisDNA, Viral

Substanzen

Alanine TransaminaseDNA, Viral

Autor:innen und Institutionen

  • Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Department of Medical Education, University of Balamand, Beirut, Lebanon.
  • HealthPartners Digestive Care, St. Paul, Minnesota.
  • Department of Internal Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
  • Department of Gastroenterology, Erasmus MC, Rotterdam, The Netherlands.

Förderung

  • FIC NIH HHS

Zitieren

APA

Tappata, M., Farah, M., Anugwom, C., Bisrat, E., Seid, A. S., & Debes, J. D. (2023). Clinical, Gender, Socioeconomic Characteristics and Outcomes of Individuals Receiving Hepatitis B Treatment in Ethiopia: 18-Month Follow-Up. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0236

Vancouver

Tappata M, Farah M, Anugwom C, Bisrat E, Seid AS, Debes JD. Clinical, Gender, Socioeconomic Characteristics and Outcomes of Individuals Receiving Hepatitis B Treatment in Ethiopia: 18-Month Follow-Up. The American Journal of Tropical Medicine and Hygiene. 2023. doi:10.4269/ajtmh.23-0236

BibTeX
@article{Tappata2023,
  author = {Tappata, Manaswita and Farah, Marina and Anugwom, Chimaobi and Bisrat, Eden and Seid, Amir S and Debes, Jose D},
  title = {Clinical, Gender, Socioeconomic Characteristics and Outcomes of Individuals Receiving Hepatitis B Treatment in Ethiopia: 18-Month Follow-Up},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2023},
  doi = {10.4269/ajtmh.23-0236}
}
Kostenlos starten →